Clinical trial Recruiting at 4 sites Interventional Ages 18 to 40 Women only

Comparing surgical techniques for treating endometriomas

Official title: BLAST: a Randomized Controlled Trial on Conservative Endometrioma Surgery Using the CO2 Laser: the Combined Technique Versus CO2 Laser Vaporization Only

Run by Universitaire Ziekenhuizen KU Leuven · NCT04151433 · Data updated 2026-11-12

This study is testing which of two surgical methods is better at preserving a woman's ability to have children while treating endometriomas.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment92 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations4 sites (Antwerp and 3 other locations)
StatusRecruiting
StartedOctober 24, 2019
Main results expectedDecember 2024
Study endsDecember 2026
Registry record updatedDecember 10, 2024
Trial IDNCT04151433 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 to 40 with unilateral endometriotic cysts between 2.5 cm and 8 cm in diameter who are experiencing infertility or pain.

Probably not a fit

Patients with a history of hysterectomy, prior unilateral oophorectomy, or those with suspected malignancy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate which of two conservative surgical techniques is more effective in preserving ovarian reserve during the treatment of endometriomas. The techniques being compared are a combined approach and CO2 laser vaporization. Ovarian reserve will be assessed through measurements of AMH serum levels taken before and after the surgery. The study targets patients who are undergoing laparoscopic surgery for endometriotic cysts.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and better preservation of ovarian function for patients with endometriomas.

How similar studies have gone: Other studies have shown promising results with similar conservative surgical approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Population: patients planned for laparoscopic CO2 laser surgery for endometriotic cysts.

Inclusion Criteria:

* Age: 18 - 40 years (both inclusive)
* Unilateral endometriotic cysts with a mean diameter of \>=2.5cm and ≤8 cm, measured in 3 dimensions.
* Presence of a contralateral endometrioma of ≤ 2cm is allowed
* Complaining of infertility and/or pain
* BMI ≤35
* Use of contraception (combined or Progesteron only) for at least 4 weeks before surgery

Exclusion Criteria:

* Incomplete surgery for the pelvis
* Contra-indication for the use of contraception (combined or Progesteron only)
* Use of GnRH analogues preoperatively and in the first 3 months postoperatively
* (History of) hysterectomy
* Prior unilateral oophorectomy
* Pituitary/hypothalamic disorders
* Suspected malignancy
* Contralateral endometrioma of \>2 cm
* AMH \<0.7 preoperatively
* Pregnancy

Where it's running

  • GZA Sint-Augustinus
    Antwerp, Belgium
    Recruiting
  • Cliniques universitaires Saint-LUC (UCL)
    Brussels, Belgium
    Recruiting
  • UZLeuven
    Leuven, Belgium
    Recruiting
  • CHR La Citadelle
    Liège, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Laparoscopic drainage plus hormonal therapy for large ovarian endometriomas

    This study will test whether laparoscopic cyst drainage followed by a GnRH agonist helps women of childbearing age with ovarian endometriomas 6 cm or larger have fewer recurrences and preserve ovarian reserve.

    Recruiting University Hospital, Lille · Lisle-sur-Tarn · NCT04704115

  • Surgical options to preserve ovaries when treating endometriomas

    This trial will see if different surgical methods for treating endometriomas help women who want to get pregnant have higher pregnancy and birth rates and fewer complications.

    Recruiting Clinique Tivoli Ducos · Bordeaux · NCT07119060

  • Ethanol sclerotherapy for treating ovarian endometriomas

    This study tests if a treatment using ultrasound-guided ethanol can help women with painful ovarian cysts shrink them and reduce their symptoms.

    Recruiting Hillel Yaffe Medical Center · Hadera · NCT06971458

  • Alcohol sclerotherapy for pelvic pain and quality of life in ovarian endometrioma

    This trial will try ultrasound-guided alcohol sclerotherapy to see if it reduces pelvic pain and improves quality of life in women aged 18–45 with ovarian endometriomas compared with expectant management.

    Recruiting at 10 sites Hospital Universitari de Bellvitge · Palma de Mallorca, Balearic Islands and 25 other locations · NCT06955221

  • Understanding how the uterus absorbs fluid during early pregnancy

    This study is trying to understand how the uterus absorbs fluid during early pregnancy in women, both with and without endometriosis, to learn more about the process.

    Recruiting Johns Hopkins University · Athens, Georgia and 2 other locations · NCT06847685

  • Treatment options for ovarian endometrioma

    This study is testing whether a new method using ethanol can treat ovarian endometriomas as well as or better than standard surgery, while also looking at how it affects women's fertility and symptoms over two years.

    Recruiting Chelsea and Westminster NHS Foundation Trust · London · NCT06775769

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.